Article Information
History
- July 23, 2021.
Article Versions
- You are currently viewing Version 1 of this article (July 23, 2021 - 10:43).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yao Zhang1,3,¶,
- Xiaohua Hao2,¶,
- Ji Ma3,
- Mingming Wang3,
- Yanyan Li3,
- Yang Liu3,
- Dong Zhao2,
- Wen Zhang2,
- Chunming Li3,
- Li Yan3,
- Qing Zhu1,3,* and
- Fujie Zhang2,*
- 1TSB Therapeutics, Beijing, China
- 2Beijing Ditan Hospital, Capital Medical University, Beijing, China
- 3Brii Biosciences Inc., Durham, NC, US
- ↵*Correspondening authors: Qing Zhu, Email address: qing.zhu{at}briibio.com (QZ), Fujie Zhang, Email address: treatment{at}chinaaids.cn (FZ)
↵¶ These authors contributed equally to this work.